|
TRIM38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66293670342566E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.78960196556477E-11 |
| Normal-vs-Stage2 |
8.06939999999923E-05 |
| Normal-vs-Stage3 |
2.177500E-03 |
| Normal-vs-Stage4 |
7.466300E-02 |
| Stage1-vs-Stage2 |
4.867200E-01 |
| Stage1-vs-Stage3 |
4.625200E-01 |
| Stage1-vs-Stage4 |
2.435200E-01 |
| Stage2-vs-Stage3 |
2.200400E-01 |
| Stage2-vs-Stage4 |
7.425600E-02 |
| Stage3-vs-Stage4 |
4.760600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63147273468667E-12 |
| Normal-vs-AfricanAmerican |
9.14639997073863E-09 |
| Normal-vs-Asian |
2.252800E-01 |
| Caucasian-vs-AfricanAmerican |
1.483850E-01 |
| Caucasian-vs-Asian |
2.686200E-01 |
| AfricanAmerican-vs-Asian |
2.968600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6672219160796E-12 |
| Normal-vs-Female |
1.53000001557047E-09 |
| Male-vs-Female |
8.903000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.009620E-04 |
| Normal-vs-Extreme_Weight |
2.1570000008353E-08 |
| Normal-vs-Obese |
2.05119999985293E-07 |
| Normal-vs-Extreme_Obese |
1.644350E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.085400E-01 |
| Normal_Weight-vs-Obese |
4.298400E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.287210E-01 |
| Extreme_Weight-vs-Obese |
9.509600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.067400E-01 |
| Obese-vs-Extreme_Obese |
9.267200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.140690E-03 |
| Normal-vs-Age(41-60Yrs) |
2.36222152949495E-12 |
| Normal-vs-Age(61-80Yrs) |
3.34432481707836E-12 |
| Normal-vs-Age(81-100Yrs) |
2.559800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.130070E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.499100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.891600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.894400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.566200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.303600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.84560000004996E-06 |
| Normal-VS-KIRP CIMP |
8.892000E-01 |
| Normal-VS-Unclassified PRCC |
6.618200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.422200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.70468999999285E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
8.368200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.614840E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.484400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.037900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.05639999995011E-06 |
| Normal-vs-N1 |
1.219710E-03 |
| Normal-vs-N2 |
7.847000E-01 |
| N0-vs-N1 |
8.216600E-01 |
| N0-vs-N2 |
9.541500E-02 |
| N1-vs-N2 |
1.203620E-01 |
|
|
